Drug-related problems identified during medication review before and after the introduction of a clinical decision support system

34Citations
Citations of this article
106Readers
Mendeley users who have this article in their library.

Your institution provides access to this article.

Abstract

What is known and objective: To facilitate the identification of drug-related problems (DRPs) during medication review, several tools have been developed. Explicit criteria, like Beers criteria or STOPP (Screening Tool of Older Peoples’ Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment) criteria, can easily be integrated into a clinical decision support system (CDSS). The aim of this study was to investigate the effect of adding a CDSS to medication review software on identifying and solving DRPs in daily pharmacy practice. Methods: Pre- to post-analysis of clinical medication reviews (CMRs) performed by 121 pharmacies in 2012 and 2013, before and after the introduction of CDSS into medication review software. Mean number of DRPs per patient, type of DRPs and their resolution rates were compared in the pharmacies pre- and post-CDSS using paired t tests. Results and discussion: In total, 9151 DRPs were identified in 3100 patients pre-CDSS and 15 268 DRPs were identified in 4303 patients post-CDSS. The mean number of identified DRPs per patient (aggregated per pharmacy) was higher after the introduction of CDSS (3.2 vs 3.6 P

Cite

CITATION STYLE

APA

Verdoorn, S., Kwint, H. F., Hoogland, P., Gussekloo, J., & Bouvy, M. L. (2018). Drug-related problems identified during medication review before and after the introduction of a clinical decision support system. Journal of Clinical Pharmacy and Therapeutics, 43(2), 224–231. https://doi.org/10.1111/jcpt.12637

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free